GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW 2,295.00
+35.00 (1.55%)
At close: Jul 25, 2025, 3:30 PM KST
GeneOne Life Science Market Cap
GeneOne Life Science has a market cap or net worth of 194.40 billion as of July 25, 2025. Its market cap has increased by 18.79% in one year.
Market Cap
194.40B
Enterprise Value
220.63B
Revenue
37.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,295.00
Market Cap Chart
Since August 30, 1995, GeneOne Life Science's market cap has increased from 3.40B to 194.40B, an increase of 5,617.77%. That is a compound annual growth rate of 14.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 194.40B | 15.14% |
| Dec 30, 2024 | 168.84B | -24.04% |
| Dec 28, 2023 | 222.27B | -59.85% |
| Dec 29, 2022 | 553.65B | -55.74% |
| Dec 30, 2021 | 1,250.93B | 30.16% |
| Dec 30, 2020 | 961.06B | 1,733.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.87T |
| Celltrion | 39.24T |
| ALTEOGEN | 24.69T |
| Yuhan | 9,152.41B |
| SK Biopharmaceuticals | 8,034.94B |
| Peptron | 6,663.04B |
| HLB Co., Ltd. | 6,558.63B |
| PharmaResearch | 5,797.42B |